Skip to main content

Chemical Entities of Biological Interest Ontology (CHEBI)

Search from vocabulary

align
annotate
download

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > polyketide > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > spiro compound > oxaspiro compound > spiroketal > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > polyketide > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic oxo compound > carbonyl compound > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > carboxylic ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > ester > lactone > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > macrocycle > macrocyclic lactone > macrolide > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > heterocyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organic heterocyclic compound > oxacycle > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > oxygen molecular entity > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > heteroorganic entity > organochalcogen compound > organooxygen compound > acetal > ketal > cyclic ketal > avermectin analogue > milbemycin > 6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone

Preferred term

6,8a-seco-6,8a-deoxy-5-oxoavermectin "2a" aglycone  

Broader concept

Belongs to group

URI

http://data.loterre.fr/ark:/67375/KFP-MHTJ8V5P-K

Download this concept:

RDF/XML TURTLE JSON-LD